Hints and tips:
Showing results for Stone v. Takeda Pharmaceuticals America Inc
Related Special Reports
...Vaccine hesitancy has become a political faultline in America, where rates of inoculation in “red” Republican states are stubbornly low....
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...(FT) A nod for Japan’s largest corporate takeover Takeda Pharmaceutical won important shareholder approval to finance its £46bn takeover of Ireland’s Shire....
...The latest acquisition contributes to a record year for Japanese outbound deals, led by Takeda Pharmaceutical’s £46bn agreement to buy Irish drugmaker Shire in April....
...Others focused on the significance of Takeda’s move for its country’s pharmaceuticals industry....
...The combined value of those deals — which include Takeda Pharmaceutical’s ¥7tn planned takeover of Shire — was around ¥11.7tn....
...Corporate giants including US cable group Comcast, wireless provider T-Mobile and Japan’s pharmaceutical maker Takeda reached for M&A to head off competitive threats and expand their businesses....
...Separately, Japan’s Takeda Pharmaceutical has reached a preliminary agreement to buy Irish drugmaker Shire for about £46bn, a deal that could spark a renewed wave of “big pharma” deals....
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
...In the latest sign of how eager boardrooms are sparking a record number of “megadeals”, Japan’s top drugmaker Takeda revealed it was weighing a $40bn takeover of Irish rival Shire....
...Separately, Hikma disclosed on Thursday that it will expand its licensing and distribution pact with Japan’s Takeda Pharmaceuticals that will add new products to its Middle East and North Africa portfolio...
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...Today, he cuts a burly figure weighing in at 13 stone. But when he entered treatment six months ago he was barely nine stone, having hardly eaten for a year....
...This will now be the challenge for new chief executive Patrick Bergin, who is being promoted from chief operating officer, to replace Stephen Stone who becomes executive chairman in March....
...Mr Modi laid the foundation stone for the new Amaravati in October 2015....
...Thomas Sheehan, head of global healthcare at Bank of America Merrill Lynch, said despite the slowdown the fundamentals for dealmaking remained unchanged and activity was bound to pick up again....
...Cancer drug maker Takeda Pharmaceutical, fell 2.6 per cent following Trump’s comments....
..., the pharmaceutical company....
...We need to move out of the Stone Age. I really hope the new WHO director-general will define priorities, deliver and be held accountable. There needs to be new blood, new people, a new vision....
...In Japan, Takeda Pharmaceutical slid 2.7 per cent, Astellas Pharma fell 3.9 per cent and Shionogi sank 3.7 per cent on Thursday morning, while in Australia biotech company CSL Ltd dropped 1.4 per cent and...
...For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical year....
...(WaPo) Clinton v Trump: clash of the operatives David Brock and Roger Stone are masters of the dark arts of politics – 2016 will be their greatest canvas....
...The investment came a day after AstraZeneca agreed to pay Takeda of Japan $575m for a portfolio of respiratory medicines and a month after it bought ZS Pharma, a US biotech company, for $2.7bn....
...The US Food and Drug Administration approved its first biosimilar earlier this year in a sign that America is finally opening to the category after years of lobbying against it from some big pharmaceuticals...
International Edition